16th DFBK-Symposium

BIOTYPE at the 16th Symposium of the Deutschen Forschungsverbundes Blasenkarzinom e.V. in Ulm!

We look forward to joining leading experts in uro-oncology to discuss the future of precision diagnostics.

Our key contributions:

Expert Insights: Vanessa Grunwald will give a talk titled "Gene expression markers in uro-oncology: Molecular profiling as an opportunity for innovation and care", highlighting the importance of novel approaches in precision diagnostics.

Assay Portfolio Expansion: BIOTYPE provides comprehensive molecular profiling solutions for various cancers, including bladder cancer, with a focus on clinically relevant biomarkers such as FGFR3. Our uro-oncology assay portfolio will further expand in 2026, and we’ll share exclusive insights at the symposium.

Improved Workflow Efficiency: Our MODAPLEX Platform streamlines diagnostic workflows by enabling multiplex biomarker analysis in under 5 hours, helping conserve FFPE tissue, time, and resources.

Better Clinical Decisions: Our mission is to improve clinical decision-making and patient outcomes with our novel technologies for profiling bladder cancer samples.

Timm Zörgiebel and Vanessa Grunwald will be on-site to share insights and discuss ideas with you in the field of uro-oncology.